Affymax, Inc. (AFFY)

OTCMKTS · Delayed Price · Currency is USD
0.0008
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST
14.29%
Market Cap 59.59K
Revenue (ttm) 42.00K
Net Income (ttm) 3.07M
Shares Out 74.49M
EPS (ttm) 0.08
PE Ratio 0.01
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 12,151
Open 0.0008
Previous Close 0.0008
Day's Range 0.0008 - 0.0008
52-Week Range 0.0006 - 0.0407
Beta 6.41
RSI 47.83
Earnings Date n/a

About Affymax

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol AFFY
Full Company Profile

Financial Performance

In 2013, Affymax's revenue was $1.37 million, a decrease of -98.55% compared to the previous year's $94.37 million. Losses were -$14.42 million, -84.56% less than in 2012.

Financial Statements

News

There is no news available yet.